Pharmacokinetics and behavioral effects of oxymorphone after intravenous and subcutaneous administration to healthy dogs.
KuKanich
B
B
PharmCATS Bioanalytical Laboratory, Department of Anatomy and Physiology, Kansas State University, Manhattan, KS, USA.
Schmidt
B K
BK
Krugner-Higby
L A
LA
Toerber
S
S
Smith
L J
LJ
D000042:Absorption; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D000818:Animals; D019540:Area Under Curve; D001522:Behavior, Animal / Q000187:drug effects; D004285:Dogs; D006207:Half-Life; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008657:Metabolic Clearance Rate; D010111:Oxymorphone / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology
D000701:Analgesics, Opioid; D010111:Oxymorphone